Evidence map›Paper›PMID 39240755›Full record

ArticleCancer control : journal of the Moffitt Cancer Center

Prognostic Impact of Malignant Wounds in Patients With Head and Neck Cancer: Secondary Analysis of a Prospective Cohort Study.

Shigemasa Takamizawa, Hiroto Ishiki, Yuma Takeda, Sayaka Arakawa, Naruaki Kawasaki, Isseki Maeda, Naosuke Yokomichi, Takashi Yamaguchi, Hiroyuki Otani, Tatsuya Morita and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shigemasa TakamizawaDepartment of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan.ORCID 0000-0001-7687-7456
Hiroto IshikiDepartment of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan.
Yuma TakedaDepartment of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan.
Sayaka ArakawaDepartment of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan.
Naruaki KawasakiDepartment of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan.
Isseki MaedaDepartment of Palliative Care, Senri-Chuo Hospital, Toyonaka, Japan.
Naosuke YokomichiDepartment of Palliative and Supportive Care, Seirei Mikatahara General Hospital, Hamamatsu, Japan.ORCID 0000-0003-0863-1184
Takashi YamaguchiDepartment of Palliative Medicine, Kobe University, Kobe, Japan.ORCID 0000-0003-3060-0245
Hiroyuki OtaniDepartment of Palliative and Supportive Care, St. Mary's Hospital, Kurume, Japan.
Tatsuya MoritaDepartment of Palliative and Supportive Care, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
Eriko SatomiDepartment of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan.
Masanori MoriDepartment of Palliative and Supportive Care, Seirei Mikatahara General Hospital, Hamamatsu, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMalignant wounds are lesions caused by metastasis from distant primary cancers or by direct invasion of the cutaneous structures of a primary cancer, and are most common in patients with breast or head and neck cancers. Malignant wounds not only cause physical symptoms, but also affect survival. Recognizing prognosis in terminal-stage cancer patients is necessary for both patients and health care providers. The prognostic impact of malignant wounds in patients with head and neck cancer has been poorly investigated.

methodsThis is a secondary analysis of the results of a prospective cohort study that investigated the dying process in patients with advanced cancer in 23 palliative care units in Japan. The primary outcome of this study was the prognostic impact of malignant wounds in patients with head and neck cancer. The difference in survival between patients with head and neck cancer who had malignant wounds and those who did not was compared using the log-rank test.

resultsOf 1896 patients admitted to palliative care units, 68 had head and neck cancer, and 29 of these had malignant wounds. Overall survival was significantly shorter in patients with malignant wounds than that in those without (median: 19.0 days vs 32.0 days,

conclusionPatients with head and neck cancer who had malignant wounds had worse overall survival than those who did not.

Indexed as

Head and Neck NeoplasmsPalliative CareAdultAgedAged, 80 and overFemaleHumansJapanMaleMiddle AgedPrognosisProspective Studiescohort studieshead and neck neoplasmsmalignant woundpalliative carepalliative prognostic indexprognosis

Identifiers

PMID39240755
PMCPMC11380123

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.